Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome

Abstract End-organ impairment has received relatively little research attention as a possible manifestation of tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS). In this prospective cohort study, one-half of adults with human immunodeficiency virus and pulmonary tuberculosis experienced meaningful declines in lung function on antiretroviral therapy, suggesting a role for lung function in TB-IRIS definitions.

[1]  D. Weissman,et al.  Lung injury on antiretroviral therapy in adults with HIV/TB. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  L. Lynen,et al.  Prednisone for the Prevention of Paradoxical Tuberculosis‐Associated IRIS , 2018, The New England journal of medicine.

[3]  Pengcheng Bu,et al.  Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis , 2018, PLoS pathogens.

[4]  P. Burney,et al.  Successfully treated but not fit for purpose: paying attention to chronic lung impairment after TB treatment. , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[5]  S. Kon,et al.  Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. , 2014, The Lancet. Respiratory medicine.

[6]  J. Wedzicha,et al.  Minimal clinically important differences in pharmacological trials. , 2014, American journal of respiratory and critical care medicine.

[7]  G. Kaplan,et al.  Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology. , 2011, The American journal of pathology.

[8]  S. Bae,et al.  Pulmonary impairment after tuberculosis and its contribution to TB burden , 2010, BMC public health.

[9]  P. Reiss,et al.  Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. , 2008, The Lancet. Infectious diseases.

[10]  R. Hopkins,et al.  Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes , 2007, European Respiratory Journal.

[11]  L. Lynen,et al.  Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  P. Price,et al.  Immune restoration disease after antiretroviral therapy , 2004, AIDS.

[13]  R. Norman,et al.  Predictors of chronic bronchitis in South African adults. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  ATS Statement , 2002 .